Medical Device Contract Manufacturing Market – Top Players and Growth Strategies
According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%.
(IINews) - According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Market growth is largely driven by the rising global disease prevalence, life expectancy, and geriatric population. Newer and advanced technologies necessitate the incorporation of advanced manufacturing methods, which result in increased overall costs.
Read More: https://www.marketsandmarkets.com/PressReleases/medical-device-contract-manufacturing.asp
While major players with sufficient resources can update their manufacturing processes to accommodate such changes, small and medium-sized manufacturers must look for contract manufacturers to save costs. Dynamic small and medium start-up companies are also turning to third-party contract manufacturers to reduce their start-up and internal costs and expedite the time-to-market of their products. This focus on manufacturing agility and flexibility to reduce costs and accelerate the time-to-market, as well as the need to maintain constant innovation, is driving the demand for contract manufacturing services.
The medical device contract manufacturing market is segmented on the basis of device type, service, class of device, and region.
On the basis of device type, cardiovascular devices and endoscopy devices are both projected to witness the highest growth during the forecast period between 2019 and 2024. The increasing prevalence of cardiovascular diseases is expected to increase the demand for cardiovascular devices in hospitals, diagnostic laboratories, and home care settings. The volume growth of cardiovascular devices, coupled with an increasing number of medical device companies opting for contract manufacturing services in order to reduce the cost of manufacturing, is expected to drive the market for cardiovascular devices during the forecast period.
By service, the final goods assembly services segment is expected to witness the highest growth during the forecast period. Market growth is largely driven by the increasing need for these services by various OEMs, medical device companies, and pharmaceutical companies that are involved in the manufacturing and sales of fully integrated single-use medical devices.
Based on the class of device, the market is broadly segmented into Class I, Class II, and Class III medical devices. The Class III medical devices segment is expected to register the highest growth during the forecast period due to the rising demand for pacemakers, implants, and ventilators. In addition to this, the manufacturing of Class III devices requires sophisticated and advanced technologies that can be a budgetary concern for small and medium-sized medical device companies.
OEMs are increasingly opting to outsource their technical and production services to contract manufacturing organizations (CMOs) to reduce their manufacturing footprint. Outsourcing the production of various components in a medical device allows manufacturers to be more dynamic and cost-effective in their production process. The consolidation of OEMs has encouraged CMOs to follow the trend and also consolidate to expand their capabilities and form strategic partnerships with their OEM customers.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851
Geographically, the Asia Pacific is expected to witness the highest CAGR during the forecast period, owing to factors such as the increasing demand for medical devices in this region due to the improving healthcare infrastructure, adoption of technologically advanced products, low cost of manufacturing, and the less stringent regulatory scenario for manufacturing of medical devices which promotes higher usage of medical devices as compared to most developed countries.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter(at)marketsandmarkets.com
Themen in diesem Fachartikel:
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Datum: 02.08.2019 - 14:32 Uhr
Sprache: Deutsch
News-ID 1742270
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner:
Stadt:
Telefon:
Kategorie:
Gesundheit & Medizin
Anmerkungen:
Dieser Fachartikel wurde bisher 93 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Medical Device Contract Manufacturing Market – Top Players and Growth Strategies
"
steht unter der journalistisch-redaktionellen Verantwortung von
MarketsandMarkets™ INC. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).